EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Bilateral Chylothorax After 13 Years of Dasatinib Therapy in a Patient With Chronic Myeloid Leukaemia: A Case Report

Riku Watanabe iD, Shin-Ichiro Iwakami, Manami Haba, Yumi Kuroda, Naoko Iwakami, Eri Fujikawa, Kazuhisa Takahashi

Respirology Case Reports · 2026-03 · 14 (3)

DOI: 10.1002/rcr2.70529 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Respirology Case Reports, online erschienen am 06.03.2026. Verfasst von Riku Watanabe und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine Juntendo University Shizuoka Hospital Izunokuni Shizuoka Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A 52‐year‐old man with chronic myeloid leukaemia (CML) who had been receiving dasatinib 100 mg/day for 13 years presented with progressive dyspnea. Chest radiography revealed bilateral pleural effusions, and further evaluation confirmed the diagnosis of chylothorax. Dasatinib‐induced chylothorax was suspected, and discontinuation of the drug led to clinical improvement. Dasatinib is a tyrosine kinase inhibitor (TKI) used for the treatment of CML and Philadelphia chromosome–positive acute lymphoblastic leukaemia (Ph + ALL). Although pleural effusion is a relatively common adverse effect, chylothorax is an extremely rare complication. This case highlights the importance of considering chylothorax as a potential cause of pleural effusion in patients undergoing long‐term dasatinib therapy. In addition, based on the presumed pathophysiological mechanism, drug discontinuation appears to be the most crucial therapeutic approach for dasatinib‐induced chylothorax.

Schlagwörter

Stichwörter der Autor:innen

bilateral chylothoraxchronic myeloid leukaemiadasatinib

Autor:innen und Institutionen

  • Department of Respiratory Medicine Juntendo University Shizuoka Hospital Izunokuni Shizuoka Japan.
  • Department of Respiratory Medicine Juntendo University Graduate School of Medicine Tokyo Japan.

ORCID-Profile: Riku Watanabe

Zitieren

APA

Watanabe, R., Iwakami, S. I., Haba, M., Kuroda, Y., Iwakami, N., Fujikawa, E., & Takahashi, K. (2026). Bilateral Chylothorax After 13 Years of Dasatinib Therapy in a Patient With Chronic Myeloid Leukaemia: A Case Report. Respirology Case Reports, 14(3). https://doi.org/10.1002/rcr2.70529

Vancouver

Watanabe R, Iwakami SI, Haba M, Kuroda Y, Iwakami N, Fujikawa E, et al. Bilateral Chylothorax After 13 Years of Dasatinib Therapy in a Patient With Chronic Myeloid Leukaemia: A Case Report. Respirology Case Reports. 2026;14(3). doi:10.1002/rcr2.70529

BibTeX
@article{Watanabe2026,
  author = {Watanabe, Riku and Iwakami, Shin-Ichiro and Haba, Manami and Kuroda, Yumi and Iwakami, Naoko and Fujikawa, Eri and Takahashi, Kazuhisa},
  title = {Bilateral Chylothorax After 13 Years of Dasatinib Therapy in a Patient With Chronic Myeloid Leukaemia: A Case Report},
  journal = {Respirology Case Reports},
  year = {2026},
  volume = {14},
  number = {3},
  doi = {10.1002/rcr2.70529}
}
Kostenlos starten →